MedPlus Health Services Limited (NSE: MEDPLUS)
730.85
+6.05 (0.83%)
Sep 6, 2024, 3:30 PM IST
MedPlus Health Services Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
Revenue | 58,294 | 56,249 | 45,576 | 37,793 | 30,693 | 28,706 | Upgrade
|
Revenue Growth (YoY) | 20.24% | 23.42% | 20.59% | 23.13% | 6.92% | 26.31% | Upgrade
|
Cost of Revenue | 45,403 | 43,916 | 35,758 | 29,938 | 24,314 | 23,433 | Upgrade
|
Gross Profit | 12,891 | 12,332 | 9,818 | 7,855 | 6,379 | 5,273 | Upgrade
|
Selling, General & Admin | 6,397 | 6,255 | 5,565 | 4,010 | 3,405 | 2,788 | Upgrade
|
Other Operating Expenses | 2,728 | 2,536 | 1,476 | 1,025 | 737.6 | 768.88 | Upgrade
|
Operating Expenses | 11,444 | 11,034 | 8,857 | 6,228 | 5,025 | 4,305 | Upgrade
|
Operating Income | 1,447 | 1,299 | 960.92 | 1,627 | 1,353 | 967.8 | Upgrade
|
Interest Expense | -978.2 | -964.33 | -830.27 | -664.28 | -536.17 | -460.72 | Upgrade
|
Interest & Investment Income | - | - | 277.88 | 137.32 | 77.94 | 85.94 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | 0.9 | -0.08 | -1.64 | -0.39 | Upgrade
|
Other Non Operating Income (Expenses) | 393.27 | 400.08 | 23.65 | 42.3 | 19.81 | 21.67 | Upgrade
|
EBT Excluding Unusual Items | 861.79 | 734.43 | 433.08 | 1,142 | 913.13 | 614.3 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | 0.3 | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | -3.54 | -1.82 | -0.98 | -3.22 | Upgrade
|
Asset Writedown | - | - | 42 | 38.18 | 23.79 | - | Upgrade
|
Other Unusual Items | - | - | - | - | 12.78 | -322.97 | Upgrade
|
Pretax Income | 861.79 | 734.43 | 471.63 | 1,179 | 950.98 | 293.59 | Upgrade
|
Income Tax Expense | 100.23 | 78.66 | -29.42 | 232.27 | 319.87 | 275.65 | Upgrade
|
Earnings From Continuing Operations | 761.56 | 655.77 | 501.05 | 947.16 | 631.11 | 17.94 | Upgrade
|
Minority Interest in Earnings | -1.06 | -1.04 | -3.42 | 10.86 | 7.47 | 3.86 | Upgrade
|
Net Income | 760.5 | 654.73 | 497.63 | 958.02 | 638.58 | 21.8 | Upgrade
|
Net Income to Common | 760.5 | 654.73 | 497.63 | 958.02 | 638.58 | 21.8 | Upgrade
|
Net Income Growth | 51.05% | 31.57% | -48.06% | 50.02% | 2829.27% | -81.71% | Upgrade
|
Shares Outstanding (Basic) | 120 | 119 | 119 | 112 | 104 | 104 | Upgrade
|
Shares Outstanding (Diluted) | 120 | 120 | 120 | 112 | 108 | 108 | Upgrade
|
Shares Change (YoY) | 1.01% | 0.40% | 6.38% | 3.83% | 0.17% | 0.14% | Upgrade
|
EPS (Basic) | 6.35 | 5.48 | 4.17 | 8.55 | 6.13 | 0.21 | Upgrade
|
EPS (Diluted) | 6.31 | 5.45 | 4.17 | 8.52 | 5.89 | 0.20 | Upgrade
|
EPS Growth | 49.54% | 30.70% | -51.06% | 44.65% | 2815.86% | -81.70% | Upgrade
|
Free Cash Flow | - | 593.38 | -785.95 | 521.68 | -513.66 | -368 | Upgrade
|
Free Cash Flow Per Share | - | 4.94 | -6.57 | 4.64 | -4.74 | -3.40 | Upgrade
|
Gross Margin | 22.11% | 21.92% | 21.54% | 20.78% | 20.78% | 18.37% | Upgrade
|
Operating Margin | 2.48% | 2.31% | 2.11% | 4.31% | 4.41% | 3.37% | Upgrade
|
Profit Margin | 1.30% | 1.16% | 1.09% | 2.53% | 2.08% | 0.08% | Upgrade
|
Free Cash Flow Margin | - | 1.05% | -1.72% | 1.38% | -1.67% | -1.28% | Upgrade
|
EBITDA | 2,184 | 1,979 | 1,412 | 1,867 | 1,520 | 1,119 | Upgrade
|
EBITDA Margin | 3.75% | 3.52% | 3.10% | 4.94% | 4.95% | 3.90% | Upgrade
|
D&A For EBITDA | 737.58 | 680.18 | 450.6 | 240.1 | 166.82 | 151.03 | Upgrade
|
EBIT | 1,447 | 1,299 | 960.92 | 1,627 | 1,353 | 967.8 | Upgrade
|
EBIT Margin | 2.48% | 2.31% | 2.11% | 4.31% | 4.41% | 3.37% | Upgrade
|
Effective Tax Rate | 11.63% | 10.71% | - | 19.69% | 33.64% | 93.89% | Upgrade
|
Revenue as Reported | 58,687 | 56,649 | 46,037 | 38,106 | 30,908 | 28,879 | Upgrade
|
Advertising Expenses | - | - | 112.6 | 67.82 | 16.78 | 60.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.